Report overview
This report contains market size and forecasts of Measles and Rubella Vaccines in global, including the following market information:
Global Measles and Rubella Vaccines Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Measles and Rubella Vaccines Market Sales, 2018-2023, 2023-2030, (K Doses)
Global top five Measles and Rubella Vaccines companies in 2022 (%)
The global Measles and Rubella Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Monovalent Vaccines Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Measles and Rubella Vaccines include Serum Institute of India Ltd., Merck & Co. Inc., GlaxoSmithKline Inc. and Takeda Pharmaceutical Company, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Measles and Rubella Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Measles and Rubella Vaccines Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Doses)
Global Measles and Rubella Vaccines Market Segment Percentages, by Type, 2022 (%)
Monovalent Vaccines
Multivalent Vaccines
Global Measles and Rubella Vaccines Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Doses)
Global Measles and Rubella Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Measles and Rubella Vaccines Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Doses)
Global Measles and Rubella Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Measles and Rubella Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Measles and Rubella Vaccines revenues share in global market, 2022 (%)
Key companies Measles and Rubella Vaccines sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Measles and Rubella Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Serum Institute of India Ltd.
Merck & Co. Inc.
GlaxoSmithKline Inc.
Takeda Pharmaceutical Company
